These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16961462)

  • 41. A Role of Suppressor of Cytokine Signaling 2 in the Regulation of Ecdysteroid Signaling Pathway in Procambarus clarkii.
    Zhu B; Dai L; Yu Y; Wang D; Peng T; Liu C
    J Exp Zool A Ecol Genet Physiol; 2016 Aug; 325(7):441-52. PubMed ID: 27461053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elongin B/C recruitment regulates substrate binding by CIS.
    Piessevaux J; De Ceuninck L; Catteeuw D; Peelman F; Tavernier J
    J Biol Chem; 2008 Aug; 283(31):21334-46. PubMed ID: 18508766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppressor of cytokine signaling 2 is induced in Huntington's disease and involved in autophagy.
    Cho K; Kim S; Choi SH
    Biochem Biophys Res Commun; 2021 Jun; 559():21-27. PubMed ID: 33933990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure and Functional Characterization of the Conserved JAK Interaction Region in the Intrinsically Disordered N-Terminus of SOCS5.
    Chandrashekaran IR; Mohanty B; Linossi EM; Dagley LF; Leung EW; Murphy JM; Babon JJ; Nicholson SE; Norton RS
    Biochemistry; 2015 Aug; 54(30):4672-82. PubMed ID: 26173083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.
    Kabir NN; Sun J; Rönnstrand L; Kazi JU
    Tumour Biol; 2014 Nov; 35(11):10581-9. PubMed ID: 25172101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of leptin signalling in hematopoietic cells using an adapted MAPPIT strategy.
    Montoye T; Piessevaux J; Lavens D; Wauman J; Catteeuw D; Vandekerckhove J; Lemmens I; Tavernier J
    FEBS Lett; 2006 May; 580(13):3301-7. PubMed ID: 16698021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function.
    Kwon S; Kim D; Rhee JW; Park JA; Kim DW; Kim DS; Lee Y; Kwon HJ
    BMC Biol; 2010 Mar; 8():23. PubMed ID: 20302626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of suppressors of cytokine signalling in human neoplasms.
    Sasi W; Sharma AK; Mokbel K
    Mol Biol Int; 2014; 2014():630797. PubMed ID: 24757565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Straightforward Protein-Protein Interaction Interface Mapping via Random Mutagenesis and Mammalian Protein Protein Interaction Trap (MAPPIT).
    Vyncke L; Masschaele D; Tavernier J; Peelman F
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reverse MAPPIT detects disruptors of protein-protein interactions in human cells.
    Lemmens I; Lievens S; Eyckerman S; Tavernier J
    Nat Protoc; 2006; 1(1):92-7. PubMed ID: 17406217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Novel Link between Gene Expression Profiles of Adult T-Cell Leukemia/Lymphoma Patients' Peripheral Blood Lymphocytes and Ferroptosis Susceptibility.
    Wang Y; Iha H
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-1beta-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells.
    Jacobsen ML; Rønn SG; Bruun C; Larsen CM; Eizirik DL; Mandrup-Poulsen T; Billestrup N
    Diabetologia; 2009 Feb; 52(2):281-8. PubMed ID: 19002429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.
    Babon JJ; Sabo JK; Soetopo A; Yao S; Bailey MF; Zhang JG; Nicola NA; Norton RS
    J Mol Biol; 2008 Sep; 381(4):928-40. PubMed ID: 18590740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor.
    Uyttendaele I; Lemmens I; Verhee A; De Smet AS; Vandekerckhove J; Lavens D; Peelman F; Tavernier J
    Mol Endocrinol; 2007 Nov; 21(11):2821-31. PubMed ID: 17666591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1.
    Whiting RJ; Payne CJ; Satiaputra J; Kucera N; Qiu TW; Irtegun S; Gunn NJ; Slavova-Azmanova NS; Mulhern TD; Ingley E
    Biochem J; 2012 Mar; 442(3):611-20. PubMed ID: 22364282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation.
    Linossi EM; Nicholson SE
    IUBMB Life; 2012 Apr; 64(4):316-23. PubMed ID: 22362562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain.
    Babon JJ; Yao S; DeSouza DP; Harrison CF; Fabri LJ; Liepinsh E; Scrofani SD; Baca M; Norton RS
    FEBS J; 2005 Dec; 272(23):6120-30. PubMed ID: 16302975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The many faces of the SOCS box.
    Piessevaux J; Lavens D; Peelman F; Tavernier J
    Cytokine Growth Factor Rev; 2008; 19(5-6):371-81. PubMed ID: 18948053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The C-terminus of CIS defines its interaction pattern.
    Lavens D; Ulrichts P; Catteeuw D; Gevaert K; Vandekerckhove J; Peelman F; Eyckerman S; Tavernier J
    Biochem J; 2007 Jan; 401(1):257-67. PubMed ID: 16961462
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.